LAFSX | RMEBX | LAFSX / RMEBX | |
Total Expense Ratio | 0.69 | 1.07 | 64% |
Annual Report Gross Expense Ratio | 0.69 | 1.07 | 64% |
Fund Existence | 10 years | 11 years | - |
Gain YTD | 12.665 | 13.105 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.4B | 111B | 6% |
Annual Yield % from dividends | 1.42 | 1.09 | 131% |
Returns for 1 year | 8.42 | 6.26 | 135% |
Returns for 3 years | 45.45 | 41.49 | 110% |
Returns for 5 years | 64.28 | 62.00 | 104% |
Returns for 10 years | 62.98 | 101.70 | 62% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GGHYX | 39.04 | 0.35 | +0.90% |
Invesco Health Care Y | |||
LDVIX | 31.20 | 0.18 | +0.58% |
AXS FTSE Vntr Cptl RetTrckr I | |||
GSVTX | 16.85 | 0.09 | +0.54% |
Goldman Sachs Large Cap Value Inv | |||
FSWFX | 74.97 | 0.28 | +0.37% |
American Funds SMALLCAP World 529-F-2 | |||
WCEYX | 23.07 | 0.07 | +0.30% |
Macquarie Core Equity Fund Class Y |